ZMD Zoommed Inc

ZoomMed Inc. (TSX VENTURE: ZMD). In the scope of the completion of the conditional exclusive agreement to acquire Praxis Sante, ZoomMed announces it has received the waiver of some conditions and thus expecting the completion of the transaction before the end of the current trimester.

Accordingly, a portion of the aggregate counterpart payable for the acquisition by the Corporation will be made through the issuance of a maximum of 3,500,000 common shares of ZoomMed at a deemed price of $0.20 per common share with another part of the counterpart being paid in cash. It should be noted that this acquisition would enable ZoomMed to diversify and consolidate its position in the Canadian Healthcare network, concurrently to its recent announcement regarding the launching and penetration of the important American Market. The marketing of Praxis Sante's products is foreseen shortly. ZoomMed will see to update the market when the transaction will reach a more advanced stage.

About ZoomMed

ZoomMed's developed the ZRx Prescriber, a technological innovative Web application that enables physicians to use a wireless device, such as the IPod Touch™, IPhone™, IPad™, Google Android™, other PDA's or computers, to write and rapidly deliver scripts. The ZRx Prescriber is quick, efficient and intuitive. Since it is a stand-alone product, it can easily be integrated to any Electronic Medical Record application (EMR).

For further information on ZoomMed, visit our Web Site; www.zoommed.com.

About Praxis Sante

PraxisLab is a new application that enhances all aspects of the prescription filling process and the complete pharmacists patient file management. Fast, efficient and user friendly, its unique development concept provides a fast access to all its functionalities, thus allowing its users to be productive with a minimum training. PraxisLab uses state-of-the-art protocols and up-to-date software standards, allowing high compatibility with existing software, as well as new generation software.

For further information about Praxis Sante Inc., please visit the Web Site; www.praxissante.com

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contacts: ZoomMed Inc. Mr. Yves Marmet and Chief Executive Officer 450-678-5457, Ext 228 info@zoommed.com www.zoommed.com